ACE inhibitor-induced angio-oedemas: Remarkable new outlooks for intensive-care/emergency medicine;ACE-hemmer-induzierte angioodeme: Beachtenswerte neue perspektiven fur die intensiv-/notfallmedizin

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 33, Issue 10, 1998, Pages 637-641

  Wernze, H ^a,b  

^a Internistische Praxis ^*

^b Internistische Praxis   (Germany)

Author keywords

ACE inhibitors; Angio oedema; Emergency; Late onset; Recurrences

Indexed keywords

ADRENALIN; CAPTOPRIL; CLEMASTINE FUMARATE; DIMETINDENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANGIONEUROTIC EDEMA; ARTICLE; CONGESTIVE HEART FAILURE; EMERGENCY TREATMENT; GERMANY; HUMAN; HYPERTENSION; RECURRENT DISEASE; RELAPSE; CHEMICALLY INDUCED DISORDER; EMERGENCY; INTENSIVE CARE; REVIEW;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EMERGENCIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; INTENSIVE CARE;

EID: 0031761233     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994824     Document Type: Article

References (37)

1. Weiner JM: Failure to recognize the association of life-threatening angio-oedema and angiotensin-converting enzyme inhibitor therapy. Aust. NZ. J. Med. 1995; 25: 241-242
2. Wood SM, Mann RD, Rawlins MD: Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. Brit. Med. J. 1987; 294: 91-92
3. Ulmer UL, Garvey MJ: Fatal angio-oedema associated with lisinopril. Pharmacotherapy 1992; 26: 245-246
4. AKdÄ: Erneuter Hinweis: ACE-Hemmer-induzierte angio-neurotische Ödeme auch bei Langzeit-Anwendung nicht übersehen. Dt. Ärztebl. 1996; 93: A2809
5. Dobroschke R, Georgi R, Krier C: Akutes angioneurotisches Ödem auf ACE-Hemmer. Anästh. Intensivmed. Notfallmed. Schmerzther. 1992; 27: 510-512
6. Tisch M, Maier H: Angioödeme der Schleimhaut des oberen Atmungs- und Verdauungstraktes nach Einnahme von ACE-Hemmern. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1997; 32: 122-123
7. Wernze H: Angioneurotisches Ödem unter ACE-Hemmern: Häufigkeit, klinische Charakteristik, Auslösemechanismen. Z. kardiol. 1988; 77: 61-64
8. Chin HL, Buchan DA: Severe angioedema after long-term use of angiotensin-converting enzyme inhibitor. Ann. Int. Med. 1990; 112: 312-313
9. Chu JT, Chow N: Adverse effects of ACE inhibitors. Ann. Int. Med. 1993; 118: 314.
10. Diehl KL, Wernze H: Angioneurotisches Ödem durch Angiotensin-Konversionsenzym-Hemmer. Dtsch. Med. Wschr. 1992; 117: 727-732
11. Brown NJ, Snoweden M, Griffin MR: Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. J. Amer. Med. Ass. 1997; 278: 232-233
12. Kozel MMA, Mekkes JR, Bos JD: Increased frequency and severity of angio-oedema related to long-term therapy with angiotensin-converting enzyme inhibitor in two patients. Clin. Exp. Dermatol. 1995; 20: 60-61
13. Frontera Y, Piecuch JF: Multiple episodes of angioedema associated with lisinopril, an ACE inhibitor. JADA 1995; 126: 217-219
14. Finlay CJ, Silverman MA, Nunez AE: Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized. Amer. J. Emerg. Med. 1992; 10: 550-552
15. Frank MM: Hereditary angioedema: The clinical syndrome and its management. Ann. Int. Med. 1976; 84: 580-593
16. Bork K: Rezidivierende Angioödeme durch C1-Inhibitor-Mangel: Erstickungsrisiko. Dt. Ärztebl. 1997; 94: B576-583
17. Bosch S: Erstickung infolge C1-Inhibitormangel. Der Notarzt 1998; 14: 39-41
18. Megerian CA, Arnold JE, Berger M: Angioedema: 5 years experience, with a review of the disorders presentation and treatment. Laryngoscope 1992; 102: 256-260
19. Soo Hoo GW, Dao HT, Klaustermeyer WB: Severe angioedema and respiratory distress associated with lisinopril use. West J. Med. 1993; 158: 412-417
20. Agah R, Bandi V, Guntupalli KK: Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intens. Care Med. 1997; 23: 793-796
21. Roberts JR, Wuerz RC: Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema. Ann. Emerg. Med. 1991; 20: 555-558
22. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK: Adverse drug reactions. Brit. Med. J. 1998; 316: 1295-1298
23. Gavras I: Bradykinin-mediated effects of ACE inhibition. Kidney Int. 1992; 42: 1020-1029
24. Fuller RW, Warren JB, McCusker M, Dollery CT: Effect of enalapril on the skin response to bradykinin in man. Brit. J. Clin. Pharmac. 1997; 23: 88-90
25. Ferner SE, Simpson JM, Rawlins MD: Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Brit. Med. J. 1987; 294: 1119-1120
26. Anderson MW, deShazo RD: Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, und histamine. J. Allergy Clin. Immunol. 1990; 85: 856-858
27. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. The Lancet 1998; 351: 1693-1697
28. Orfan N, Patterson R, Dykewicz MS: Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. J. Amer. Med. Ass. 1990; 264: 1287-1289
29. Agostini A, Cicardi M: Contraindications to the use of ACE inhibitors in patients with C1 Esterase inhibitor deficiency. Amer. J. Med. 1991; 90: 278
30. Langauer Messmer S, Schiller P, Bircher AJ: Glottic angioedema, ciprofloxacin, and ACE-inhibitors. Postgrad. Med. J. 1996; 72: 383
31. Roy TM, Byrd RP, Fields CL: Upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest 1993; 104: 1310
32. Brown NJ, Ray WA, Snowden M, Griffin MR: Black americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin. Pharmacol. Ther. 1996; 60: 8-13
33. Kharasch ED: Angiotensin-converting enzyme inhibitor-induced angioedema associated with endotracheal intubation. Anaesth. Analg. 1992; 74: 602-604
34. Jain M, Armstrong L, Hall J: Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest 1992; 102: 871-874
35. Schwabe U: Überblick über die Arzneiverordnungen im Jahre 1996. Schwabe U: Arzneiverordnungsreport '97. Stuttgart. Fischer 1997
36. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. J Am Med Assoc 1998; 279: 1200-1205
37. Bates DW: Drugs and adverse drug reactions. How worried should we be? J Am Med Assoc 1998; 279: 1216-1217